Viewing Study NCT00004204


Ignite Creation Date: 2025-12-24 @ 8:02 PM
Ignite Modification Date: 2026-05-15 @ 7:28 AM
Study NCT ID: NCT00004204
Status: UNKNOWN
Last Update Posted: 2014-01-06
First Post: 2000-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor: Herbert Irving Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult brain tumor View
None adult anaplastic astrocytoma View
None adult anaplastic oligodendroglioma View